Skip to main content

Mid-Year Meeting 2023 Main banner

Browse by Speaker

Browse by Speaker

Type here to filter the list

All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

H
Harborg, Sixten

Aarhus University
OP2-6 - Post-diagnostic statin use and breast cancer-specific mortality: a population-based cohort study
Location: Room A
Sixten Harborg
Havard, Alys

National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia
OP1-6 - Prenatal exposure to antipsychotic medication and neurocognitive impairment among children: A Nordic cohort study
Location: Room A
Alys Havard
Hayes, Kaleen

Brown University School of Public Health, Providence, Rhode Island, USA
OP3-6 - Post-Acute Care Setting after Hip Fracture Hospitalization and Subsequent Opioid Use in Older Adults
Location: Room A
Kaleen Hayes
Henrard, Séverine

1. Clinical Pharmacy Research Group, Louvain Drug Research Institute (LDRI), Université catholique de Louvain, Brussels, Belgium. 2. Institute of Health and Society (IRSS), Université catholique de Louvain, Brussels, Belgium
OP2-1 - Non-adherence to Direct Oral Anticoagulants among new users and old users in patients with atrial fibrillation in French clinical practice
Location: Room A
Séverine Henrard
Hernandez, Rohini

Amgen, Inc.
OP1-2 - Characterizing Fit-for-Purpose Real-World Data: An Assessment of a Mother–Infant Linkage in the Japan Medical Data Center Claims Database
Location: Room A
Rohini Hernandez
Hjellvik, Vidar

Norwegian Institute of Public Health
OP1-6 - Prenatal exposure to antipsychotic medication and neurocognitive impairment among children: A Nordic cohort study
Location: Room A
Vidar Hjellvik
Hudgens, Michael

Gillings School of Global Public Health, University of North Carolina at Chapel Hill
OP3-4 - Utilization of Treat-to-Target Monitoring Colonoscopy after Treatment Initiation in the US-Based Study of a Prospective Adult Research Cohort with Inflammatory Bowel Disease (SPARC IBD)
Location: Room A
Michael Hudgens